OBI Pharma, Inc.: OBI Pharma Announces Poster Presentations at AACR 2022 Annual Meeting for OBI-3424 and Globo H Science

Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug) and emerging Globo H science. TAIPEI, Taiwan, April 7, 2022 /PRNewswire/ -- OBI Pharma

Related Keywords

Taipei ,T Ai Pei ,Taiwan ,Chung Shan ,T Ai Chung ,United States ,Changhua ,Zhanghua Xian ,American ,Adagloxad Simolenin ,Chun Chung Wang ,Lu Tzu Chen ,Jhih Jie Yang ,Kevin Poulos ,Kostenloser Wertpapierhandel ,Jiann Shiun Lai ,Cheng Yen Wei ,Chih Chan Lee ,School Of Medicine ,American Association Of Cancer Research ,Pharma United States Inc ,Obi Pharma Inc ,Chung Shan Medical University ,Futures Bureau ,Department Of Pathology ,Pharma Inc ,Poster Presentations ,American Association ,Cancer Research ,Annual Meeting ,New Orleans ,Scientific Officer ,Ming Tain Lai ,High Globo H ,Changhua Christian Hospital ,Globo Series ,Private Securities Litigation Reform Act ,Taiwan Securities ,Pharma ,Nnounces ,Poster ,Presentations ,Racr ,022 ,Nnual ,Meeting ,424 ,Globo ,Science ,